1American diabetes association.Report of the expert committee on the diagnosis and classification of diabetes mellitus[J].Diabete Care,1997,20(7):1183-202.
2Wagner FW.The dysvascuhr foot:a system for diagnosis and treat-ment[J].Foot Ankle,1981,2(2):64-122.
6Sohn MW,Lee TA,Stuck RM,et al.Mortality risk of charcot ar-thropathy compared with that of diabetic foot ulcer and diabetes a-lone[J].Diabetes Care,2009,32(5):816-21.
4Musa H G, Ahmed M E. Associated risk factors and management of chronic diabetic foot ulcers exceeding 6 months' duration [J]. Diabet Foot Ankle, 2012,3:18980-http://dx.doi.org/10.3402/dfa. v3i0.18980.
5Chong S J, Kwan T M, Weihao L, et al. Maintenance of negative- pressure wound therapy while undergoing hyperbaric oxygen thera- py[J]. Diving Hyperb Med, 2011,41 ( 3 ): 147.
6Wagner FW Jr. The dysvascular foot :a system for diagnosis and treatment [ J ]. Foot Ankle, 1981,2 ( 2 ) :64 -122.
7Hobot J, Walker M, Newman G, et al. Effect of Hydrofiber wound dressings on bacterial ultrastructure [ J ]. J Microsc (Tokyo), 2008,57 (2) :67-75.
8Luo G, Tang J, He W, et al. Antibacterial effect of dressings containing multivalent silverion carried by zirconium phosphate on experimental rat burn wounds [ J ]. Wound Repair Regen ,2008,16 (6) :800-804.
